Maintaining a healthy weight is good for your body and can also help with self-esteem. If you’ve been trying to lose weight, ...

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move ...

Heavy drinkers who were ­taking weight-loss jabs in a Dublin clinic significantly reduced their ­alcohol intake down from 12 ...

EXPERTS have warned over hundreds rushed to hospital after using weight loss jabs – as half a million Brits now use the ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

デンマークの製薬大手ノボノルディスクは24日、次世代肥満症薬「アミクレチン」の初期臨床試験で、最大22％の減量効果が見られたと発表した。結果を受け、同社の株はコペンハーゲン株式市場で一時14％高と、2023年８月以来の上昇幅となった。